about
Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infectionIncreased mortality associated with HTLV-II infection in blood donors: a prospective cohort studyHepatitis C virus/human T lymphotropic virus 1/2 co-infection: Regional burden and virological outcomes in people who inject drugsTransfusion-transmitted infectionsTransmission of Tropical and Geographically Restricted Infections during Solid-Organ TransplantationVirus markers associated with vertical transmission of human T lymphotropic virus type 1 in JamaicaEtiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectEpidemiological analysis of HTLV-1 and HTLV-2 infection among different population in Central ChinaHigh seroprevalence of human T-cell lymphotropic virus type 1 in blood donors in Guyana and molecular and phylogenetic analysis of new strains in the Guyana shelf (Guyana, Suriname, and French Guiana)Human T-lymphotropic virus type 1 (HTLV-1) prevalence and quantitative detection of DNA proviral load in individuals with indeterminate/positive serological resultsEffect of human T-cell lymphotrophic virus type 1 (HTLV-1) in seropositive infertile women on intracytoplasmic sperm injection (ICSI) outcomeLupus nephritis class I accompanied by tubulointerstitial nephritis with marked T-lymphocyte infiltration in an HTLV-1 positive patientExpression of glucose transporter 1 confers susceptibility to human T-cell leukemia virus envelope-mediated fusion.Emergence of a novel and highly divergent HTLV-3 in a primate hunter in Cameroon.The oncoprotein Tax binds the SRC-1-interacting domain of CBP/p300 to mediate transcriptional activation.Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesisSerological, epidemiological, and molecular differences between human T-cell lymphotropic virus Type 1 (HTLV-1)-seropositive healthy carriers and persons with HTLV-I Gag indeterminate Western blot patterns from the Caribbean.Infectious disease issues in xenotransplantation.Molecular epidemiology and clinical features of human T cell lymphotropic virus type 1 infection in SpainRationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes ProjectThe functional TP53 rs1042522 and MDM4 rs4245739 genetic variants contribute to Non-Hodgkin lymphoma riskMother-to-Child Transmission of Human T-Cell Lymphotropic Viruses-1/2: What We Know, and What Are the Gaps in Understanding and Preventing This Route of Infection.The high-affinity Sp1 binding site in the HTLV-1 promoter contributes to Tax-independent basal expressionEvaluation of HTLV-1 activity in HAM/TSP patients using proviral load and Tax mRNA expression after In Vitro lymphocyte activation.Adult T-cell leukemia/lymphoma: a rare case in the USA and review of the literature.Post-transplantation HTLV-1 myelopathy in three recipients from a single donor.Human T-cell leukemia virus type 1 integration target sites in the human genome: comparison with those of other retroviruses.Phenotypic and genotypic comparisons of human T-cell leukemia virus type 1 reverse transcriptases from infected T-cell lines and patient samples.Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection.HTLV-1-associated infective dermatitis and probable HTLV-1- associated myelopathy in an adolescent female.In contrast to HIV, KIR3DS1 does not influence outcome in HTLV-1 retroviral infectionHuman T-lymphotropic virus type 1 and type 2 seroprevalence, incidence, and residual transfusion risk among blood donors in Brazil during 2007-2009Cotranscriptional Chromatin Remodeling by Small RNA Species: An HTLV-1 PerspectiveClinical manifestations associated with HTLV type I infection: a cross-sectional studyEtiologic heterogeneity among non-Hodgkin lymphoma subtypes.Functional domain structure of human T-cell leukemia virus type 2 rex.Enhancement of LFA-1-mediated T cell adhesion by human T lymphotropic virus type 1 p12I1.Human T cell lymphotropic virus type 1 infection and early neurologic development: a pilot study of 48 childrenAnalysis of the Prevalence of HTLV-1 Proviral DNA in Cervical Smears and Carcinomas from HIV Positive and Negative Kenyan Women.Endemic impact of human T cell leukemia virus type 1 screening in bone allografts.
P2860
Q24658333-D932FB6C-C944-4B01-9DD8-BBF254807B72Q24804881-DA11A1C3-D5A6-4849-99FF-78576AC9EB98Q26749788-7DA7F75A-E7A7-4BAB-85B2-F061F48B5FE7Q27480405-E7D4EB2F-9F44-4833-BE37-4BBA5AB72732Q27485255-5140DD68-F609-4E92-A678-17527C62F527Q28200964-6D50587E-5B40-4E12-BA84-DEFB489326D4Q28393769-C92D24F2-EFA3-4873-9848-1CA3106DE111Q28534288-B9F38A3D-3F21-4883-AD65-3A5F2E2849F5Q29354015-D0E546F0-E532-4273-9BE1-18ACBD0E4D6DQ33235267-1F349F2B-1157-4F8B-A815-BA04E7111CBDQ33564457-5CEA1059-8E99-4EBA-9FD4-1AE906FAA44AQ33622071-1F505121-8A95-4547-99D5-208F5D34A3D5Q33707390-48E37C7B-2B35-45E4-8F7A-37D3062148BFQ33820713-4EEBD2D5-A60D-4A33-A3B9-4EC65D2B9F02Q33969220-81320DB2-906A-4EBD-942E-EC19691D4019Q33969941-5DD8C369-6F98-44B8-A0D1-8BA77011B35FQ33971770-C96EA646-1518-4929-963B-9D19CBE66F42Q33975598-81C15202-9784-48B4-ADFE-937B8768439FQ34116882-4125B81E-DA18-443C-A3A6-5C1D461A01AFQ34137915-3ECDB36C-B0AC-4832-B27D-DE98B1D8B938Q34156039-95ABAA37-1F7C-48AE-830C-81F914819FD3Q34181725-28477EAA-79CB-48E8-AB38-286C4BA8B941Q34333483-1C01A65F-F77C-487C-8C75-9A5AD278BCDAQ34567129-9D874A11-5BA2-4B9F-8664-A57275F139E6Q34573955-227A3E09-47B1-4C11-A212-A8D05F572551Q35475269-4AC3BC21-7209-4013-97D1-3E792997AB28Q35857184-1AA91621-0A21-407E-8CE8-1A41B39FE797Q35857436-7A2B104A-570C-4C00-9F8F-2C6D87304272Q35879289-37A7843F-3985-4274-99E8-6654963EFB1BQ35967196-683A1228-E8AE-4619-9511-FE3830494142Q36110061-2B572704-399B-4392-962A-65110C2CD111Q36250371-88CA83EA-2B92-4587-BA6D-66D90528B446Q36417492-433A840C-778B-4442-B894-68CA92E097EBQ36994979-939C88B3-91BC-4212-8D22-2B3593792BAEQ37003547-AA9FC29B-6697-48F8-AEC7-9B641AB814A8Q37059755-E5C41765-7582-45ED-8E01-190C43CC655FQ37156338-868ACE31-CD3E-4B16-8F8F-3B9153E1F6B0Q37182373-3ABEC033-30C4-46B2-8871-A038C6ECDE9BQ37281763-A66D7374-307D-4C7E-B425-0976AA62B698Q37423645-FF6F82BB-23ED-4978-86DF-764F0E884C22
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Human T-lymphotropic virus type I infection.
@ast
Human T-lymphotropic virus type I infection.
@en
type
label
Human T-lymphotropic virus type I infection.
@ast
Human T-lymphotropic virus type I infection.
@en
prefLabel
Human T-lymphotropic virus type I infection.
@ast
Human T-lymphotropic virus type I infection.
@en
P2093
P1433
P1476
Human T-lymphotropic virus type I infection.
@en
P2093
P304
P356
10.1016/S0140-6736(98)09460-4
P407
P577
1999-06-01T00:00:00Z